PHE has published the second antenatal screening standards data report, covering 1 April 2018 to 31 March 2019.
Posted by:
Lizzie Tempest ,
Posted on: 12 October 2020
-
Categories:
NHS Abdominal Aortic Aneurysm Screening Programme ,
NHS Bowel Cancer Screening Programme ,
NHS Breast Screening Programme ,
NHS Cervical Screening Programme ,
NHS Diabetic Eye Screening Programme ,
NHS Fetal Anomaly Screening Programme ,
NHS Infectious Diseases in Pregnancy Screening Programme ,
NHS Newborn and Infant Physical Examination ,
NHS Newborn Blood Spot Screening Programme ,
NHS Newborn Hearing Screening Programme ,
NHS Sickle Cell and Thalassaemia Screening Programme
We have published the fourth and final set of quarterly key performance indicator (KPI) data for the 2019 to 2020 year.
PHE has published a refreshed suite of documents for finding data definitions and submitting KPI data.
Posted by:
Lizzie Tempest ,
Posted on: 6 July 2020
-
Categories:
General information ,
NHS Abdominal Aortic Aneurysm Screening Programme ,
NHS Bowel Cancer Screening Programme ,
NHS Breast Screening Programme ,
NHS Cervical Screening Programme ,
NHS Diabetic Eye Screening Programme ,
NHS Fetal Anomaly Screening Programme ,
NHS Infectious Diseases in Pregnancy Screening Programme ,
NHS Newborn and Infant Physical Examination ,
NHS Newborn Blood Spot Screening Programme ,
NHS Newborn Hearing Screening Programme ,
NHS Sickle Cell and Thalassaemia Screening Programme
PHE Screening has now published the third set of quarterly key performance indicator (KPI) data for the 2019 to 2020 year.
PHE Screening has introduced a new standard into the NHS Fetal Anomaly Screening Programme (FASP).
We have published the annual data report for the NHS Sickle Cell and Thalassaemia (SCT) Screening Programme covering 1 April 2017 to 31 March 2018.
The first joint antenatal screening data report is out
Posted by:
Lizzie Tempest ,
Posted on: 20 February 2020
-
Categories:
General information ,
NHS Abdominal Aortic Aneurysm Screening Programme ,
NHS Bowel Cancer Screening Programme ,
NHS Breast Screening Programme ,
NHS Cervical Screening Programme ,
NHS Diabetic Eye Screening Programme ,
NHS Fetal Anomaly Screening Programme ,
NHS Infectious Diseases in Pregnancy Screening Programme ,
NHS Newborn and Infant Physical Examination ,
NHS Newborn Blood Spot Screening Programme ,
NHS Newborn Hearing Screening Programme ,
NHS Sickle Cell and Thalassaemia Screening Programme
We have published the second set of quarterly key performance indicator (KPI) data for the 2019 to 2020 year.
PHE Screening is delighted to publish its first annual data report on the national cervical screening programme standards, focusing on performance in England from 1 April 2018 to 31 March 2019.
Posted by:
Lizzie Tempest ,
Posted on: 10 January 2020
-
Categories:
General information ,
NHS Abdominal Aortic Aneurysm Screening Programme ,
NHS Bowel Cancer Screening Programme ,
NHS Breast Screening Programme ,
NHS Cervical Screening Programme ,
NHS Diabetic Eye Screening Programme ,
NHS Fetal Anomaly Screening Programme ,
NHS Infectious Diseases in Pregnancy Screening Programme ,
NHS Newborn and Infant Physical Examination ,
NHS Newborn Blood Spot Screening Programme ,
NHS Newborn Hearing Screening Programme ,
NHS Sickle Cell and Thalassaemia Screening Programme
We have published the annual screening data for the key performance indicators (KPIs) for the 2018 to 2019 screening year (1 April 2018 to 31 March 2019).
